| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
146,367
|
134,259
|
205,604
|
104,577
| | Cost of Revenue | 166,853 | 154,731 | 194,741 | 108,650 | | |
Gross Profit
|
(20,486)
|
(20,472)
|
10,863
|
(4,073)
| |
|
Operating Expenses |
|
Research Development | 6,405 | 9,168 | 8,929 | 6,049 |
|
Selling General and Administrative | 24,553 | 35,365 | 32,542 | 37,994 |
|
Non Recurring |
-
| 270,140 |
-
|
-
|
|
Others | 8,223 | 9,854 | 9,724 | 2,279 |
|
|
|
Total Operating Expenses |
-
| 324,527 |
-
|
-
| | | |
Operating Income or Loss
|
(59,667)
|
(344,999)
|
(40,332)
|
(50,395)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (129) | 965 | 1,852 | (33,769) |
|
Earnings Before Interest And Taxes | (71,445) | (366,150) | (28,760) | (93,969) |
|
Interest Expense |
-
| (14,989) | 14,989 |
-
|
|
Income Before Tax | (71,445) | (351,161) | (43,749) | (93,969) |
|
Income Tax Expense | (28,112) | 4,367 | (28,957) | (27,302) |
|
Minority Interest | (818) | (1,706) | (3,440) | (680) |
|
|
|
Net Income From Continuing Ops | (47,223) | (359,578) | (18,894) | (67,604) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(47,223)
|
(359,578)
|
(18,894)
|
(67,604)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(47,223)
|
(359,578)
|
(18,894)
|
(67,604)
|
|